A business in context

OSRH research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-07 · 8016 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-30 · 0001213900-26-106429 · Items 5.02

  2. 8-K · Current report

    Report date 2026-08-27 · 0001213900-26-094654 · Items 8.01

  3. 8-K · Current report

    Report date 2026-08-25 · 0001213900-26-093379 · Items 8.01

  4. 8-K · Current report

    Report date 2026-08-19 · 0001213900-26-091756 · Items 3.01,7.01,9.01

  5. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001213900-26-089904

  6. 8-K · Current report

    Report date 2026-08-07 · 0001213900-26-087087 · Items 5.07

  7. 8-K · Current report

    Report date 2026-08-07 · 0001213900-26-086599 · Items 7.01,9.01

  8. 8-K · Current report

    Report date 2026-07-31 · 0001213900-26-083878 · Items 7.01,9.01

  9. DEF 14A · Proxy statement

    Report date 2026-08-07 · 0001213900-26-078706

  10. 8-K · Current report

    Report date 2026-06-11 · 0001213900-26-069524 · Items 5.03,9.01

  11. 8-K · Current report

    Report date 2026-06-05 · 0001213900-26-067732 · Items 8.01

  12. 8-K · Current report

    Report date 2026-05-27 · 0001213900-26-064037 · Items 1.01,9.01

  13. DEF 14A · Proxy statement

    Report date 2026-06-18 · 0001213900-26-061078

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001213900-26-055492

  15. 8-K/A · Current report

    Report date 2026-04-29 · 0001213900-26-052922 · Items 9.01

  16. 8-K · Current report

    Report date 2026-04-29 · 0001213900-26-049967 · Items 1.01,7.01,9.01

  17. 8-K · Current report

    Report date 2026-04-16 · 0001213900-26-046711 · Items 5.02

  18. 8-K · Current report

    Report date 2026-04-07 · 0001213900-26-041768 · Items 1.01,2.03,3.02,7.01,9.01

  19. 8-K/A · Current report

    Report date 2026-03-27 · 0001213900-26-039691 · Items 9.01

  20. 8-K · Current report

    Report date 2025-03-27 · 0001213900-26-039278 · Items 1.01,9.01

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001213900-26-037395

  22. 8-K · Current report

    Report date 2026-03-13 · 0001213900-26-027984 · Items 7.01

  23. 8-K · Current report

    Report date 2026-03-05 · 0001213900-26-025428 · Items 3.01,9.01

  24. 8-K · Current report

    Report date 2026-01-26 · 0001213900-26-007987 · Items 2.01,7.01,9.01

  25. 8-K · Current report

    Report date 2025-01-13 · 0001213900-26-004199 · Items 1.01,7.01,9.01

  26. 8-K · Current report

    Report date 2025-11-21 · 0001213900-25-114496 · Items 7.01,8.01,9.01

  27. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001213900-25-109054

  28. 8-K · Current report

    Report date 2025-10-13 · 0001213900-25-099393 · Items 1.01,7.01,9.01

  29. 8-K · Current report

    Report date 2025-09-17 · 0001213900-25-090340 · Items 5.07

  30. 8-K · Current report

    Report date 2025-09-05 · 0001213900-25-086209 · Items 3.01

  31. 8-K · Current report

    Report date 2025-09-03 · 0001213900-25-085670 · Items 8.01

  32. DEF 14A · Proxy statement

    Report date 2025-09-17 · 0001213900-25-082061

  33. 4 · Ownership change

    Report date 2025-02-14 · 0001213900-25-015409

  34. 4 · Ownership change

    Report date 2025-02-14 · 0001213900-25-015406

  35. 4 · Ownership change

    Report date 2023-03-23 · 0000898432-23-000171

  36. 4 · Ownership change

    Report date 2023-03-23 · 0000898432-23-000169

  37. 4 · Ownership change

    Report date 2023-03-23 · 0000898432-23-000167

  38. 4 · Ownership change

    Report date 2023-02-21 · 0000898432-23-000125

  39. 4 · Ownership change

    Report date 2023-02-21 · 0000898432-23-000124

  40. 4 · Ownership change

    Report date 2023-02-14 · 0000899243-23-005318

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-07 · 1614 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001840425OSR Health, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-07 · 1179 checked identities; 0 unavailable records

Search names and former names
  • OSR Holdings, Inc. · former SEC name · 2023-12-20 to 2026-06-11
  • Bellevue Life Sciences Acquisition Corp. · former SEC name · 2021-03-12 to 2025-02-13

Revenue in constant purchasing power

USD revenue expressed in 2026-08 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$3.53M$3.77M

Bureau of Labor Statistics · retrieved 2026-10-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗